Related Experiment Video

Updated: Aug 13, 2026

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
07:23

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification

Published on: December 3, 2016

Non-conventional growth hormone treatment in short children

O Westphal1

  • 1Department of Paediatrics and Child Psychiatry, East Hospital, Göteborg, Sweden.

Acta Endocrinologica
|June 1, 1993
PubMed

Insights

Growth hormone (GH) treatment for non-conventional childhood indications lacks sufficient final height data. Further research is needed to optimize GH therapy for both physical growth and psychosocial development.

Area of Science:

  • Pediatric Endocrinology
  • Growth Hormone Therapy
  • Child Development

Background:

  • Growth hormone (GH) is available for treating various childhood conditions.
  • Data on final height outcomes for non-conventional indications of GH therapy are limited.
  • Optimizing GH treatment requires considering both physical and psychosocial aspects.

Purpose of the Study:

  • To highlight the need for more research on final height outcomes in children receiving GH for non-conventional indications.
  • To emphasize the importance of evaluating psychosocial development alongside physical growth in GH treatment.

Main Methods:

  • This study is a review of existing literature and clinical practice regarding GH therapy.
  • Analysis of available data on final height in pediatric patients undergoing GH treatment.
  • Assessment of psychosocial development metrics in relation to GH therapy.

Main Results:

  • Current data on final height outcomes for non-conventional GH indications are insufficient or based on small patient cohorts.
  • A significant knowledge gap exists regarding the long-term effects of GH treatment on final height.
  • The impact of GH on psychosocial development requires further comprehensive investigation.

Conclusions:

  • More extensive research is crucial to establish optimal GH treatment protocols for non-conventional childhood indications.
  • Future studies should focus on gathering robust data on final height and psychosocial well-being.
  • A holistic approach is necessary to maximize the benefits of GH therapy in children.

More Related Videos

Treatment of Ligament Constructs with Exercise-conditioned Serum: A Translational Tissue Engineering Model08:03

Treatment of Ligament Constructs with Exercise-conditioned Serum: A Translational Tissue Engineering Model

Published on: June 11, 2017

Tricolor Transgenic Murine Model for Studying Growth Plate Injury07:58

Tricolor Transgenic Murine Model for Studying Growth Plate Injury

Published on: September 6, 2024

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...